RNAZ: TransCode Therapeutics, Inc. Stock

by  •  • Comments Off on RNAZ: TransCode Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.19
Enterprise Value ($M) 0.43
Book Value ($M) 1.64
Book Value / Share 0.28
Price / Book 1.95
NCAV ($M) 0.93
NCAV / Share 0.16
Price / NCAV 3.45

Profitability (mra)
Return on Invested Capital (ROIC) -8.87
Return on Assets (ROA) -3.32
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.28
Current Ratio 1.28

Balance Sheet (mrq) ($M)
Current Assets 4.46
Assets 5.17
Liabilities 3.53
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -19.42
Net Income -18.55

Cash Flow Statement (mra) ($M)
Cash From Operations -18.07
Cash from Investing -0.04
Cash from Financing 15.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-15 13G/A Medarova Zdravka 0.40 -93.25
02-14 13G/A Tang Capital Partners Lp 0.00 -100.00
02-13 13G/A Lind Global Fund II LP 0.10 -98.95
10-10 13D/A Dudley Robert Michael 1.90 104.19

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 248,897 43,579 571.14
2024-04-25 504,634 130,877 385.58
2024-04-24 21,819 9,578 227.80
2024-04-23 39,073 24,474 159.65

(click for more detail)

Similar Companies
RGC – Regencell Bioscience Holdings Limited RGLS – Regulus Therapeutics Inc.
RMTI – Rockwell Medical, Inc. RNXT – RenovoRx, Inc.
RVPH – Reviva Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io